Diabetes & Dental Implants: Real-World Outcomes of CorticoBasal® Protocols in Type II Patients

Diabetes, especially Type II, has always posed significant challenges in implant dentistry. Elevated blood sugar levels, delayed wound healing, often compromise the outcome of dental implants. However, real-world studies now demonstrate that with the right protocols, diabetic patients can achieve success rates nearly identical to those of non-diabetic individuals. Among the most effective advancements, CorticoBasal® Implants have emerged as a transformative solution.

Clinical Insights from Research

A systematic review, based on PRISMA guidelines and comprising 23 high-quality studies, evaluated the performance of dental implants in Type II diabetic patients. The results showed 93.67% success rate with 6.33% failure rate. The study highlighted important influencing factors: HbA1c levels (average 7.26%), age (average 52.41 years), number of implants, and the duration of diabetes (average 7.46 years). Controlled blood sugar directly correlated with better outcomes, while uncontrolled diabetes increased implant failure due to poor healing and higher infection susceptibility.

In comparison, non-diabetic individuals showed a success rate of 98.68%. It confirms that when Type-II diabetes is well-managed, then it may not necessarily prevent patients from receiving implants, provided modern implantology protocols are followed.

Why CorticoBasal® Implants Excel in Diabetic Patients

The unique advantage of CorticoBasal® Implants lies in their minimally invasive, immediate-loading approach. Unlike traditional methods that rely heavily on bone grafting and extended healing, CorticoBasal® technology anchors implants into the dense cortical bone, bypassing weak or compromised areas. This not only reduces the risk of delayed healing but also allows patients to receive fixed teeth within 48 to 72 hours. This stays true for diabetic patients as well, who prefer its minimal complications, and stable, long-term outcomes.

Dr. Vivek Gaur’s Real-World Success

In the Delhi NCR region, Dr. Vivek Gaur has consistently demonstrated exceptional outcomes for diabetic patients through CorticoBasal® protocols. His expertise in this implantology combined with Swiss technology ensures that all the patients receive durable, precise, safe and efficacious care. With thousands of successful implant cases, he has proven that diabetes is no longer a barrier to restoring a confident smile.

In summary, CorticoBasal® Implants have redefined implantology for diabetic patients, offering immediate, reliable, and complication-free results. Under the guidance of Dr. Vivek Gaur, Type II diabetes patients can now access world-class dental implants with outcomes that rival those of non-diabetic individuals.